文献速递乳腺乳腺X线

挪威乳腺癌筛查中数字乳腺断层摄影联合合成二维乳腺摄影与标准二维数字乳腺摄影后的间期癌及连续轮次乳腺癌比较

Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway.
PubMed 文献 · Radiology · 2019-12-10

该前瞻性队列研究纳入挪威乳腺癌筛查项目92404名基线筛查女性,比较数字乳腺断层摄影联合合成二维乳腺摄影(研究组)与标准二维数字乳腺摄影(对照组)的间期乳腺癌发生率及特征。研究组与对照组间期癌率分别为每1000名筛查女性2.0例与1.5例(P=0.12),组织病理学特征无差异。连续筛查轮次中,研究组筛查检出癌率为每1000名筛查女性3.9例,低于对照组的5.6例(P=0.001)。

要点

  • 数字乳腺断层摄影联合合成二维乳腺摄影组间期癌率为每1000名筛查女性2.0例,标准二维数字乳腺摄影组为1.5例(P=0.12)。
  • 连续筛查轮次中,研究组筛查检出癌率为每1000名筛查女性3.9例,对照组为5.6例(P=0.001)。
  • 连续筛查中组织学1级浸润癌率研究组为每1000名筛查女性0.5例,对照组为1.3例(P=0.001)。

核心结论

  • 数字乳腺断层摄影联合合成二维乳腺摄影筛查女性与标准二维数字乳腺摄影筛查女性相比,间期乳腺癌发生率及肿瘤特征无差异。
  • 连续筛查轮次中对照组低级别筛查检出肿瘤发生率更高。

研究设计与样本

  • 前瞻性队列研究,来自挪威乳腺癌筛查项目,纳入2014年2月至2015年12月基线筛查女性。
  • 研究组34641名女性采用数字乳腺断层摄影联合合成二维乳腺摄影筛查,对照组57763名女性采用标准二维数字乳腺摄影筛查。
  • 连续筛查轮次中,研究组26474名女性及对照组45543名女性在2年后接受二维数字乳腺摄影筛查。
  • 采用χ2检验、t检验(Bonferroni校正后P<0.001表示差异有统计学意义)及二项回归模型分析组间差异。

诊断标准与关键数值

  • 间期乳腺癌率:研究组每1000名筛查女性2.0例,对照组每1000名筛查女性1.5例(P=0.12)。
  • 连续筛查轮次筛查检出乳腺癌率:研究组每1000名筛查女性3.9例,对照组每1000名筛查女性5.6例(P=0.001)。
  • 连续筛查轮次组织学1级浸润癌率:研究组每1000名筛查女性0.5例,对照组每1000名筛查女性1.3例(P=0.001)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Screening that includes digital breast tomosynthesis (DBT) with two-dimensional (2D) synthetic mammography (SM) or standard 2D digital mammography (DM) results in detection of more breast cancers than does screening with DM alone. A decrease in interval breast cancer rates is anticipated but is not reported. Purpose To compare rates and characteristics of (a) interval breast cancer in women screened with DBT and SM versus those screened with DM alone and (b) screen-detected breast cancer at consecutive screenings with DM. Materials and Methods This prospective cohort study from BreastScreen Norway included women screened with DBT and SM (study group) or DM alone (control group) between February 2014 and December 2015 (baseline). All women, except nonattendees, women with breast cancer, and those who exceeded the upper age limit, were consecutively screened with DM after 2 years. Interval breast cancer, sensitivity, and specificity were estimated for women screened at baseline. Recall, screen-detected breast cancer, and positive predictive value were analyzed for consecutively screened women. A χ2 test, t test (P < .001 after Bonferroni correction indicated a significant difference), and binomial regression model were used to analyze differences across groups. Results A total of 92 404 women who underwent baseline screening (mean age, 59 years ± 6 [standard deviation]) were evaluated; 34 641 women in the study group (mean age, 59 years ± 6) were screened with DBT and SM and 57 763 women in the control group (mean age, 59 years ± 6) were screened with DM. A total of 26 474 women in the study group (mean age, 60 years ± 5) and 45 543 women in the control group (mean age, 60 years ± 5) were consecutively screened with DM. Rates of interval breast cancer were 2.0 per 1000 screened women in the study group and 1.5 per 1000 screened women in the control group (P = .12). No differences in histopathologic characteristics of interval breast cancer were observed. In the consecutive screening round, rates of screen-detected breast cancer were 3.9 per 1000 screened women (study group) and 5.6 per 1000 screened women (control group) (P = .001). Rates of histologic grade 1 invasive cancer were 0.5 per 1000 screened women (study group) and 1.3 per 1000 screened women (control group) (P = .001). Conclusion No differences in interval breast cancer rates or tumor characteristics were observed in women screened with DBT and SM compared with women screened with DM. Higher rates of low-grade screen-detected tumors were observed in the control group at consecutive screening. © RSNA, 2019 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Hovda T, Holen ÅS, Lång K, et al. Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway. Radiology. 2019. PMID: 31821118. doi:10.1148/radiol.2019191337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。